239 related articles for article (PubMed ID: 3457999)
1. Aluminum and renal bone disease in Australia.
Dunstan CR; Evans RA
Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
[No Abstract] [Full Text] [Related]
2. Changes in bone histology after treatment with desferrioxamine.
Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
[No Abstract] [Full Text] [Related]
3. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
[No Abstract] [Full Text] [Related]
4. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
Winney RJ; Cowie JF; Robson JS
Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
[No Abstract] [Full Text] [Related]
5. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
[No Abstract] [Full Text] [Related]
6. Effect of aluminum on bone and cell localization.
Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
[No Abstract] [Full Text] [Related]
7. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Andress DL; Endres DB; Ott SM; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
[No Abstract] [Full Text] [Related]
8. Aluminum intoxication of bone in renal failure--fact or fiction?
Malluche HH; Faugere MC; Smith AJ; Friedler RM
Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
[No Abstract] [Full Text] [Related]
9. [Toxic effect of aluminum in chronic renal failure].
Głuszek J
Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
[No Abstract] [Full Text] [Related]
10. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
[TBL] [Abstract][Full Text] [Related]
11. Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
Hercz G; Andress DL; Norris KC; Shinaberger JH; Slatopolsky EA; Sherrard DJ; Coburn JW
Trans Assoc Am Physicians; 1987; 100():139-46. PubMed ID: 3455064
[No Abstract] [Full Text] [Related]
12. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
[No Abstract] [Full Text] [Related]
13. Clinical and biochemical features of aluminum-related bone disease.
Ihle BU; Becker GJ; Kincaid-Smith PS
Kidney Int Suppl; 1986 Feb; 18():S80-6. PubMed ID: 3458003
[No Abstract] [Full Text] [Related]
14. Sporadic aluminum osteomalacia: identification of patients at risk.
Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M
Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100
[TBL] [Abstract][Full Text] [Related]
15. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
Visser WJ; Van de Vyver FL
Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
[TBL] [Abstract][Full Text] [Related]
16. The natural course of dialysis osteomalacia.
Llach F; Felsenfeld AJ; Coleman MD; Keveney JJ; Pederson JA; Medlock TR
Kidney Int Suppl; 1986 Feb; 18():S74-9. PubMed ID: 3458001
[No Abstract] [Full Text] [Related]
17. Osteomalacia associated with aluminum intoxication in a patient with chronic renal failure.
Bauer TW; Popowniak KL; Stulberg BN; McMahon JT
Cleve Clin Q; 1985; 52(2):271-8. PubMed ID: 4028429
[No Abstract] [Full Text] [Related]
18. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
[No Abstract] [Full Text] [Related]
19. Osteomalacia and bone disease arising from aluminum.
Coburn JW; Norris KC; Nebeker HG
Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
[No Abstract] [Full Text] [Related]
20. [The general principles of the diagnosis of dialysis osteomalacia by the results of the histomorphometry of spongy bone].
Novikov AI; Ivanov AE; Golovniak IE; Baeva LB; Levitskiĭ ER
Ter Arkh; 1991; 63(12):107-10. PubMed ID: 1803585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
